Clinical Trial Update: Real-World Evidence on the Cardiovascular Safety of CONTRAVE® in the United States (U.S.)

View source ↗

Summary

A real-world evidence study evaluated the cardiovascular safety of CONTRAVE (bupropion/naltrexone) for obesity in the United States; the study has completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CONTRAVE (bupropion/naltrexone)

Snippet

Sponsor: Currax Pharmaceuticals | Conditions: Obesity | Status: COMPLETED | Results posted: 2025-06-17